• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰丝氨酸协调肌浆融合器膜插入以驱动成肌细胞融合。

Phosphatidylserine orchestrates Myomerger membrane insertions to drive myoblast fusion.

机构信息

Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.

Section on Membrane Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892.

出版信息

Proc Natl Acad Sci U S A. 2022 Sep 20;119(38):e2202490119. doi: 10.1073/pnas.2202490119. Epub 2022 Sep 12.

DOI:10.1073/pnas.2202490119
PMID:36095199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9499509/
Abstract

Muscle cell fusion is a multistep process where the final step of the reaction drives progression beyond early hemifusion events to complete fusion. This step requires activity of the muscle-specific fusogen Myomerger, a single-pass transmembrane protein containing 84 amino acids with an ectodomain that includes two α-helices. Previous studies have demonstrated that Myomerger acts by destabilizing membranes through generation of elastic stresses in the outer leaflet of the plasma membrane. An obvious question is how such destabilizing activity might be regulated to avoid membrane and cellular damage, and how the two juxtaposed helices cooperate in fusion. Using cellular fusion assays and in vitro liposome assays, we report that the two helices possess unique characteristics, both of which are needed for full activity of the protein. We demonstrate that externalized phosphatidylserine (PS), a lipid previously implicated in myoblast fusion, has a determinant role in the regulation of Myomerger activity. The membrane-proximal, amphipathic Helix-1 is normally disordered and its α-helical structure is induced by PS, making membrane interactions more efficacious. The distal, more hydrophobic Helix-2 is intrinsically ordered, possesses an ability to insert into membranes, and augments the membrane-stressing effects of Helix-1. These data reveal that Myomerger fusogenic activity is an exquisitely orchestrated event involving its two ectodomain helices, which are controlled by membrane lipid composition, providing an explanation as to how its membrane-stressing activity is spatially and temporally regulated during the final step of myoblast fusion.

摘要

肌细胞融合是一个多步骤的过程,反应的最后一步推动进展超越早期半融合事件,以完成融合。这一步需要肌特异性融合剂 Myomerger 的活性,Myomerger 是一种单次跨膜蛋白,包含 84 个氨基酸,其胞外域包含两个α-螺旋。先前的研究表明,Myomerger 通过在外质层产生弹性应力来破坏质膜来发挥作用。一个明显的问题是这种破坏活性如何被调节以避免膜和细胞损伤,以及两个并列的螺旋如何在融合中协作。使用细胞融合测定和体外脂质体测定,我们报告说这两个螺旋具有独特的特性,这两个特性都是该蛋白完全活性所必需的。我们证明,先前被认为与成肌细胞融合有关的外显化磷脂酰丝氨酸(PS)在 Myomerger 活性的调节中起着决定作用。膜近端的两亲性 Helix-1 通常是无规则的,其α-螺旋结构由 PS 诱导,使膜相互作用更有效。位于远端的、疏水性更强的 Helix-2 本质上是有序的,具有插入膜的能力,并增强了 Helix-1 的膜应力效应。这些数据表明,Myomerger 的融合活性是一个精巧协调的事件,涉及其两个胞外域螺旋,这些螺旋受膜脂组成的控制,解释了其在成肌细胞融合的最后一步中如何在空间和时间上调节其膜破坏活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/e5fe630e4681/pnas.2202490119fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/867c758f3f92/pnas.2202490119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/05e9ab4b7fd6/pnas.2202490119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/cc33013cce37/pnas.2202490119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/733aa34b0633/pnas.2202490119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/5b1a2f242cc9/pnas.2202490119fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/e5fe630e4681/pnas.2202490119fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/867c758f3f92/pnas.2202490119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/05e9ab4b7fd6/pnas.2202490119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/cc33013cce37/pnas.2202490119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/733aa34b0633/pnas.2202490119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/5b1a2f242cc9/pnas.2202490119fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79b/9499509/e5fe630e4681/pnas.2202490119fig06.jpg

相似文献

1
Phosphatidylserine orchestrates Myomerger membrane insertions to drive myoblast fusion.磷脂酰丝氨酸协调肌浆融合器膜插入以驱动成肌细胞融合。
Proc Natl Acad Sci U S A. 2022 Sep 20;119(38):e2202490119. doi: 10.1073/pnas.2202490119. Epub 2022 Sep 12.
2
Myomerger promotes fusion pore by elastic coupling between proximal membrane leaflets and hemifusion diaphragm.肌联蛋白通过临近膜小叶和半融合膈膜之间的弹性偶联促进融合孔形成。
Nat Commun. 2021 Jan 21;12(1):495. doi: 10.1038/s41467-020-20804-x.
3
Myomaker and Myomerger Work Independently to Control Distinct Steps of Membrane Remodeling during Myoblast Fusion.肌生成因子和肌融合因子独立工作以控制成肌细胞融合过程中膜重塑的不同步骤。
Dev Cell. 2018 Sep 24;46(6):767-780.e7. doi: 10.1016/j.devcel.2018.08.006. Epub 2018 Sep 6.
4
The regulatory role of Myomaker and Myomixer-Myomerger-Minion in muscle development and regeneration.Myomaker、Myomixer-Myomerger-Minion 在肌肉发育和再生中的调节作用。
Cell Mol Life Sci. 2020 Apr;77(8):1551-1569. doi: 10.1007/s00018-019-03341-9. Epub 2019 Oct 23.
5
Myomerger induces fusion of non-fusogenic cells and is required for skeletal muscle development.肌联融合诱导非融合细胞融合,是骨骼肌发育所必需的。
Nat Commun. 2017 Jun 1;8:15665. doi: 10.1038/ncomms15665.
6
Myoblast fusion confusion: the resolution begins.肌母细胞融合之谜:谜底开始揭晓。
Skelet Muscle. 2018 Jan 31;8(1):3. doi: 10.1186/s13395-017-0149-3.
7
[Molecular regulation mechanism of and in myoblast fusion].[成肌细胞融合过程中[具体物质1]和[具体物质2]的分子调控机制] 需注意,原文中部分内容缺失,我根据格式推测补充了[具体物质1]和[具体物质2],以便完整呈现句子结构。实际翻译时请根据准确的原文信息进行。
Yi Chuan. 2019 Dec 20;41(12):1110-1118. doi: 10.16288/j.yczz.19-232.
8
Expression of Myomaker and Myomerger in myofibers causes muscle pathology.肌生成素和肌融合蛋白在肌纤维中的表达导致肌肉病理学。
Skelet Muscle. 2023 May 1;13(1):8. doi: 10.1186/s13395-023-00317-z.
9
Regulation of the myoblast fusion reaction for muscle development, regeneration, and adaptations.肌肉发育、再生和适应过程中肌母细胞融合反应的调控。
Exp Cell Res. 2022 Jun 15;415(2):113134. doi: 10.1016/j.yexcr.2022.113134. Epub 2022 Mar 31.
10
IL-4 Signaling Promotes Myoblast Differentiation and Fusion by Enhancing the Expression of MyoD, Myogenin, and Myomerger.IL-4 信号通过增强 MyoD、Myogenin 和 Myomerger 的表达促进成肌细胞分化和融合。
Cells. 2023 Apr 29;12(9):1284. doi: 10.3390/cells12091284.

引用本文的文献

1
Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism.双等位基因MYMX变异导致一种伴有可识别的面神经麻痹、生长受限和畸形的综合征性先天性肌病。
Eur J Hum Genet. 2025 Apr;33(4):552-555. doi: 10.1038/s41431-024-01759-9. Epub 2024 Dec 12.
2
Dietary "Beigeing" Fat Contains More Phosphatidylserine and Enhances Mitochondrial Function while Counteracting Obesity.饮食诱导的“米色化”脂肪含有更多磷脂酰丝氨酸,可增强线粒体功能并对抗肥胖。
Research (Wash D C). 2024 Sep 26;7:0492. doi: 10.34133/research.0492. eCollection 2024.
3
Ectopic expression of Myomaker and Myomixer in slow muscle cells induces slow muscle fusion and myofiber death.

本文引用的文献

1
Evolution of a chordate-specific mechanism for myoblast fusion.成肌细胞融合的脊索动物特异性机制的进化。
Sci Adv. 2022 Sep 2;8(35):eadd2696. doi: 10.1126/sciadv.add2696.
2
The cellular architecture and molecular determinants of the zebrafish fusogenic synapse.斑马鱼融合突触的细胞结构和分子决定因素。
Dev Cell. 2022 Jul 11;57(13):1582-1597.e6. doi: 10.1016/j.devcel.2022.05.016. Epub 2022 Jun 15.
3
Impaired activity of the fusogenic micropeptide Myomixer causes myopathy resembling Carey-Fineman-Ziter syndrome.融合微肽 Myomixer 活性受损导致类似于 Carey-Fineman-Ziter 综合征的肌病。
异位表达 Myomaker 和 Myomixer 在慢肌细胞中诱导慢肌融合和肌纤维死亡。
J Genet Genomics. 2024 Nov;51(11):1187-1203. doi: 10.1016/j.jgg.2024.08.006. Epub 2024 Aug 30.
4
Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases.骨骼肌:分子结构、肌发生、生物学功能及疾病
MedComm (2020). 2024 Jul 10;5(7):e649. doi: 10.1002/mco2.649. eCollection 2024 Jul.
5
Molecular regulation of myocyte fusion.肌细胞融合的分子调控。
Curr Top Dev Biol. 2024;158:53-82. doi: 10.1016/bs.ctdb.2024.01.016. Epub 2024 Mar 16.
6
Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.解析并破坏遗传性血红细胞增多症中 PIEZO1-TMEM16F 的相互作用。
Blood. 2024 Jan 25;143(4):357-369. doi: 10.1182/blood.2023021465.
7
Muscle Progenitor Cell Fusion in the Maintenance of Skeletal Muscle.肌肉祖细胞融合在维持骨骼肌中的作用。
Results Probl Cell Differ. 2024;71:257-279. doi: 10.1007/978-3-031-37936-9_13.
8
Report and Abstracts of the 19th Meeting of the Interuniversity Institute of Myology: Assisi, October 20-23, 2022.第19届大学间肌病学研究所会议报告及摘要:阿西西,2022年10月20日至23日。
Eur J Transl Myol. 2023 Jun 16;33(2). doi: 10.4081/ejtm.2023.11321.
9
Expression of Myomaker and Myomerger in myofibers causes muscle pathology.肌生成素和肌融合蛋白在肌纤维中的表达导致肌肉病理学。
Skelet Muscle. 2023 May 1;13(1):8. doi: 10.1186/s13395-023-00317-z.
J Clin Invest. 2022 Jun 1;132(11). doi: 10.1172/JCI159002.
4
Phosphatidylserine receptors enhance SARS-CoV-2 infection.磷脂酰丝氨酸受体增强 SARS-CoV-2 感染。
PLoS Pathog. 2021 Nov 19;17(11):e1009743. doi: 10.1371/journal.ppat.1009743. eCollection 2021 Nov.
5
All for One and One for All: Regenerating Skeletal Muscle.众志成城:修复骨骼肌。
Cold Spring Harb Perspect Biol. 2022 Aug 1;14(8):a040824. doi: 10.1101/cshperspect.a040824.
6
Skeletal muscle fibers count on nuclear numbers for growth.骨骼肌纤维依靠细胞核数量来生长。
Semin Cell Dev Biol. 2021 Nov;119:3-10. doi: 10.1016/j.semcdb.2021.04.015. Epub 2021 May 8.
7
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.抑制 TMEM16 蛋白的药物可阻断 SARS-CoV-2 刺突诱导的合胞体。
Nature. 2021 Jun;594(7861):88-93. doi: 10.1038/s41586-021-03491-6. Epub 2021 Apr 7.
8
Flagging fusion: Phosphatidylserine signaling in cell-cell fusion.标记融合:细胞-细胞融合中的磷脂酰丝氨酸信号。
J Biol Chem. 2021 Jan-Jun;296:100411. doi: 10.1016/j.jbc.2021.100411. Epub 2021 Feb 11.
9
Myomerger promotes fusion pore by elastic coupling between proximal membrane leaflets and hemifusion diaphragm.肌联蛋白通过临近膜小叶和半融合膈膜之间的弹性偶联促进融合孔形成。
Nat Commun. 2021 Jan 21;12(1):495. doi: 10.1038/s41467-020-20804-x.
10
Cell Fusion: Merging Membranes and Making Muscle.细胞融合:融合细胞膜并形成肌肉
Trends Cell Biol. 2019 Dec;29(12):964-973. doi: 10.1016/j.tcb.2019.09.002. Epub 2019 Oct 21.